Corvus Pharmaceuticals, Inc. (CRVS)
Since May 05, 2016, Corvus Pharmaceuticals, Inc. (CRVS) has reported earnings 42 times. On average the shares move ±5.43% post-earnings, with a positive reaction 52.4% of the time. Its largest post-earnings gain was +32.24% (May 08, 2025) and its largest decline was -14.76% (Mar 25, 2025). The next earnings report is predicted for 2026-11-06 (estimated).
Earnings reactions
How CRVS moved on each past earnings report.
Earnings Impact
Total Earnings
42
Avg Abs. Movement
±5.43%
Positive %
52.4%
Negative %
47.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☽ POST | +0.5% | open_in_new |
| May 07, 2026 | ☽ POST | +6.27% | open_in_new |
| Mar 12, 2026 | ☽ POST | -4.31% | open_in_new |
| Nov 04, 2025 | ☽ POST | -1.44% | open_in_new |
Earnings Count
42
Total earnings in dataset
Avg Abs. Movement
±5.43%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260807 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260727 | open_in_new SEC.gov |
| 8-K | 20260722 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
Frequently asked about CRVS earnings
When does Corvus Pharmaceuticals, Inc. report earnings next? expand_more
Corvus Pharmaceuticals, Inc. (CRVS)'s next earnings date is estimated for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CRVS stock move after earnings? expand_more
Over 42 reports, CRVS has moved an average of ±5.43% the session after earnings, closing higher 52.4% of the time.
What was CRVS's biggest post-earnings move? expand_more
CRVS's largest post-earnings gain on record was +32.24% on May 08, 2025, and its largest decline was -14.76% on Mar 25, 2025.
Where can I find Corvus Pharmaceuticals, Inc.'s SEC filings? expand_more
All of Corvus Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right